China issues first joint cartel and abuse fine to epinephrine maker
Shutterstock/Lost_in_the_Midwest
China’s competition authority has for the first time ever sanctioned a company for cartel conduct and abuse of dominance in a single case – slapping an active pharmaceutical ingredient supplier with a €37.7 million penalty.
To read more
Subscribe to Global Competition Review
Subscribe to unlock unlimited access
Get news, unique commentary, expert analysis and essential resources from the Global Competition Review experts.
Subscribe now